Nomura Maintains Neutral Ratings on Apollo Hospitals and Fortis
Nomura estimates the government's 30% cap on trade margins for non-scheduled anti-cancer drugs could have a mid-to-high single-digit impact on EBITDA at its covered hospitals.
Nomura estimates the government's 30% cap on trade margins for non-scheduled anti-cancer drugs could have a mid-to-high single-digit impact on EBITDA at its covered hospitals.